Eye drop trial aims to halt diabetic vision damage
Disease control
Completed
This study tested whether a new eye drop called INV-102 could help control diabetic retinopathy, a common cause of vision loss. It involved 19 adults with diabetes who had swelling in the back of the eye. Researchers gave participants the eye drops for 8-12 weeks to see if it red…
Phase: PHASE2 • Sponsor: Invirsa, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC